Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 16389 [2020-06073]

Download as PDF Federal Register / Vol. 85, No. 56 / Monday, March 23, 2020 / Notices of the ITAAC are met; and (3) any NRC inspections for the ITAAC have been completed and any ITAAC findings associated with that ITAAC have been closed. The NRC’s review process for IPCNs is similar to that for ICNs but focuses on how the licensee addressed the new, material information giving rise to the IPCN. The NRC staff’s determination of the successful completion of these ITAAC is based on information available at this time and is subject to the licensee’s ability to maintain the condition that the acceptance criteria are met. If the NRC staff receives new information that suggests the NRC staff’s determination on any of these ITAAC is incorrect, then the NRC staff will determine whether to reopen that ITAAC (including withdrawing the NRC staff’s determination on that ITAAC). The NRC staff’s determination will be used to support a subsequent finding, pursuant to 10 CFR 52.103(g), at the end of construction that all acceptance criteria in the combined license are met. The ITAAC closure process is not finalized for these ITAAC until the NRC makes an affirmative finding under 10 CFR 52.103(g). Any future updates to the status of these ITAAC will be reflected on the NRC’s website at https:// www.nrc.gov/reactors/new-reactors/ oversight/itaac.html. This notice fulfills the NRC staff’s obligations under 10 CFR 52.99(e)(1) to publish a notice in the Federal Register of the NRC staff’s determination of the successful completion of inspections, tests, and analyses. jbell on DSKJLSW7X2PROD with NOTICES Vogtle Electric Generating Plant Unit 3, Docket No. 5200025 A complete list of the review status for VEGP Unit 3 ITAAC, including the submission date and ADAMS Accession Number for each ICN received, the ADAMS Accession Number for each VEF, and the ADAMS Accession Numbers for the inspection reports associated with these specific ITAAC, can be found on the NRC’s website at https://www.nrc.gov/reactors/newreactors/new-licensing-files/vog3icnsr.pdf. Vogtle Electric Generating Plant Unit 4, Docket No. 5200026 A complete list of the review status for VEGP Unit 4 ITAAC, including the submission date and ADAMS accession number for each ICN and IPCN received, the ADAMS accession number for each VEF, and the ADAMS accession numbers for the inspection reports associated with these specific ITAAC, can be found on the NRC’s website at https://www.nrc.gov/reactors/new- VerDate Sep<11>2014 17:26 Mar 20, 2020 Jkt 250001 reactors/new-licensing-files/vog4icnsr.pdf. Dated at Rockville, Maryland, this 17th day of March 2020. For the Nuclear Regulatory Commission. Victor E. Hall, Chief, Vogtle Project Office, Office of Nuclear Reactor Regulation. [FR Doc. 2020–06057 Filed 3–20–20; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice U.S. Nuclear Regulatory Commission. ACTION: Re-notice of meeting. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on March 30, 2020. This meeting notice, published in the Federal Register on February 19, 2020, is being re-noticed to inform members of the public that this meeting will now be conducted on March 30, 2020 via teleconference. DATES: March 30, 2020 from 9:30 a.m. to 5:00 p.m. Eastern Standard Time. FOR FURTHER INFORMATION CONTACT: Ms. Kellee Jamerson, email: Kellee.Jamerson@nrc.gov, telephone: (301) 415–7408. SUPPLEMENTARY INFORMATION: The current agenda and any updates are available at http://www.nrc.gov/readingrm/doc-collections/acmui/meetings/ 2020.html or by emailing Ms. Kellee Jamerson at the contact information above. The agenda is subject to change. Purpose: Discuss issues related to 10 CFR part 35 Medical Use of Byproduct Material. Public Participation: Any member of the public who wishes to participate in the meeting should contact Ms. Jamerson using the information above. The meeting will also use the WebEx application. SUMMARY: Conduct of the Meeting Darlene Metter, M.D. will chair the meeting. Dr. Metter will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Jamerson using the contact information listed above. All submittals must be received by March 25, 2020, three business days before the PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 16389 meeting, and must pertain to the topics on the agenda for the meeting. 2. Questions and comments from members of the public will be permitted at designated times during the meeting, at the discretion of the ACMUI Chairman. 3. The draft transcript and meeting summary will be available on the ACMUI’s website http://www.nrc.gov/ reading-rm/doc-collections/acmui/ meetings/2020.html on or about May 12, 2020. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission’s regulations in Title 10 of the Code of Federal Regulations, Part 7. Dated at Rockville, Maryland this 18th day of March, 2020. For the U.S. Nuclear Regulatory Commission. Russell E. Chazell, Advisory Committee Management Officer. [FR Doc. 2020–06073 Filed 3–20–20; 8:45 am] BILLING CODE 7590–01–P OFFICE OF PERSONNEL MANAGEMENT Submission for Review: 3206–0216, We Need Important Information About Your Eligibility for Social Security Disability Benefits, RI 98–7 Office of Personnel Management. ACTION: 60-Day notice and request for comments. AGENCY: The Retirement Services, Office of Personnel Management (OPM) offers the general public and other federal agencies the opportunity to comment on a revised information collection request (ICR), We Need Important Information About Your Eligibility for Social Security Disability Benefits, RI 98–7. DATES: Comments are encouraged and will be accepted until May 22, 2020. ADDRESSES: You may submit comments, identified by docket number and title, by any of the following methods: • Federal eRulemaking Portal: http:// www.regulations.gov. Follow the instructions for submitting comments. Instructions: All submissions received must include the agency name, docket number and title for this Federal Register document. The general policy for comments and other submissions from members of the public is to make these submissions available for public viewing on the internet at http:// SUMMARY: E:\FR\FM\23MRN1.SGM 23MRN1

Agencies

[Federal Register Volume 85, Number 56 (Monday, March 23, 2020)]
[Notices]
[Page 16389]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-06073]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Re-notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a 
meeting of the Advisory Committee on the Medical Uses of Isotopes 
(ACMUI) on March 30, 2020. This meeting notice, published in the 
Federal Register on February 19, 2020, is being re-noticed to inform 
members of the public that this meeting will now be conducted on March 
30, 2020 via teleconference.

DATES: March 30, 2020 from 9:30 a.m. to 5:00 p.m. Eastern Standard 
Time.

FOR FURTHER INFORMATION CONTACT: Ms. Kellee Jamerson, email: 
[email protected], telephone: (301) 415-7408.

SUPPLEMENTARY INFORMATION: The current agenda and any updates are 
available at http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2020.html or by emailing Ms. Kellee Jamerson at the contact 
information above. The agenda is subject to change.
    Purpose: Discuss issues related to 10 CFR part 35 Medical Use of 
Byproduct Material.
    Public Participation: Any member of the public who wishes to 
participate in the meeting should contact Ms. Jamerson using the 
information above. The meeting will also use the WebEx application.

Conduct of the Meeting

    Darlene Metter, M.D. will chair the meeting. Dr. Metter will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Jamerson using the contact information listed 
above. All submittals must be received by March 25, 2020, three 
business days before the meeting, and must pertain to the topics on the 
agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted at designated times during the meeting, at the discretion of 
the ACMUI Chairman.
    3. The draft transcript and meeting summary will be available on 
the ACMUI's website http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2020.html on or about May 12, 2020.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10 of the Code of Federal Regulations, Part 7.

    Dated at Rockville, Maryland this 18th day of March, 2020.

    For the U.S. Nuclear Regulatory Commission.
Russell E. Chazell,
Advisory Committee Management Officer.
[FR Doc. 2020-06073 Filed 3-20-20; 8:45 am]
 BILLING CODE 7590-01-P